<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01336777</url>
  </required_header>
  <id_info>
    <org_study_id>1R01DK080436</org_study_id>
    <nct_id>NCT01336777</nct_id>
  </id_info>
  <brief_title>Regional Fat Depots and Insulin Resistance</brief_title>
  <official_title>Heterogeneity of Fat Depots</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The biological basis for insulin resistance associated with obesity is unknown. By studying&#xD;
      equally-overweight/obese individuals who are either insulin resistant or insulin sensitive,&#xD;
      the investigators will compare characteristics of fat tissue to test several hypotheses: 1)&#xD;
      impaired differentiation and fat storage in the subcutaneous fat depot characterize insulin&#xD;
      resistant individuals, who have, as a result, fat in other tissues like liver and muscle, as&#xD;
      well as more fat circulating in the blood; 2) inflammation is greater in visceral and/or&#xD;
      subcutaneous adipose tissue depots in insulin resistant individuals as compared with insulin&#xD;
      sensitive individuals.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Insulin resistance (IR) is a major contributor to obesity-related morbidities such as&#xD;
      diabetes and cardiovascular disease. While obesity is associated with IR, the biological&#xD;
      basis for this association is unclear, and not all obese individuals are IR. The once-popular&#xD;
      portal hypothesis, which states that lipolysis from VAT in particular accounts for IR, has&#xD;
      been questioned because VAT contributes only 15% of the total systemic free fatty acid (FFA)&#xD;
      flux. Other proposed mechanisms linking obesity to IR include inflammation, adiponectin, and&#xD;
      ectopic fat. It is unclear whether VAT mass is more closely linked to IR than is subcutaneous&#xD;
      adipose tissue (SAT) mass. Furthermore, evidence linking differential biological activity to&#xD;
      IR in VAT or SAT is indirect, largely derived from studies comparing lean to obese or VAT to&#xD;
      SAT without evaluation of IR. Thus, the purpose of this study is to investigate the&#xD;
      biological mechanisms by which SAT and/or VAT contribute to IR. Specifically, the&#xD;
      investigators will explore two related hypotheses- that impaired adipocyte differentiation in&#xD;
      SAT is related to IR, ectopic fat deposition and expansion of VAT depot, and that&#xD;
      inflammation in VAT is associated with IR. Utilizing adipose cell size/distribution obtained&#xD;
      by Beckman Coulter Multisizer, gene expression via quantitative PCR, in-vivo quantification&#xD;
      of IR via a modified insulin suppression test, and CT scans of abdomen/thigh, our specific&#xD;
      aims are to:&#xD;
&#xD;
        1. Confirm that impairment of adipocyte differentiation in SAT is associated with IR by&#xD;
           comparing cell size characteristics and differentiation markers in IR and IS subjects&#xD;
           undergoing elective surgery;&#xD;
&#xD;
        2. Test the hypothesis that the same relationship will not be seen in VAT;&#xD;
&#xD;
        3. Demonstrate that VAT mass is expanded in the presence of impaired differentiation of&#xD;
           adipocytes in SAT;&#xD;
&#xD;
        4. Demonstrate that intramuscular fat is related to both IR and impaired differentiation of&#xD;
           adipocytes in SAT using cell size characteristics and differentiation markers;&#xD;
&#xD;
        5. Demonstrate that increased inflammation in omental fat is associated with IR independent&#xD;
           of obesity using inflammation markers (gene and protein).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>August 2009</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Adipose Cell Size</measure>
    <time_frame>3 years</time_frame>
    <description>Harvest adipose tissue from human biopsy. Prepare for cell size analysis using Beckman Multisizer Coulter Counter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Macrophage density</measure>
    <time_frame>3 years</time_frame>
    <description>Human adipose tissue will be formalin-fixed and paraffin-blocked for immunohistochemical analysis to identify macrophage number and pattern</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gene Expression</measure>
    <time_frame>3 years</time_frame>
    <description>Adipose tissue from humans will be frozen and RNA prepared for measurement of relative expression of genes related to adipose cell differentiation, fat storage, and inflammation</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Obesity</condition>
  <condition>Insulin Resistance</condition>
  <condition>Diabetes Mellitus Type 2</condition>
  <arm_group>
    <arm_group_label>Insulin resistant group</arm_group_label>
    <description>there is no intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insulin sensitive group</arm_group_label>
    <description>There is no intervention</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      adipose tissue samples will be frozen for gene expression analysis.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy, nondiabetic volunteers will be recruited from Stanford's General Surgery&#xD;
        Preoperative Clinic, Stanford's Bariatric Surgery Clinic, and nonsurgical volunteers who&#xD;
        respond to local newspaper advertisements.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  No major organ disease&#xD;
&#xD;
          -  Fasting blood glucose &lt; 126 mg/dL&#xD;
&#xD;
          -  BMI 25-35 kg/m2&#xD;
&#xD;
          -  Nonpregnant/nonlactating&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy/lactation&#xD;
&#xD;
          -  major organ disease&#xD;
&#xD;
          -  drugs that influence insulin resistance&#xD;
&#xD;
          -  unstable body weight or active weight loss program&#xD;
&#xD;
          -  outside BMI range or age range&#xD;
&#xD;
          -  diabetic by fasting glucose criteria 126 mg/dL or higher&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>39 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <study_first_submitted>March 30, 2011</study_first_submitted>
  <study_first_submitted_qc>April 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2011</study_first_posted>
  <last_update_submitted>December 2, 2013</last_update_submitted>
  <last_update_submitted_qc>December 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Tracey McLaughlin</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>adipocyte differentiation</keyword>
  <keyword>inflammation</keyword>
  <keyword>insulin resistance</keyword>
  <keyword>visceral fat</keyword>
  <keyword>regional fat depots</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

